Wellgen Medical Showcases CellDetect Pro at the Taiwan Society of Clinical Cytology Annual Meeting

Wellgen Medical participated in the Taiwan Society of Clinical Cytology (TACS) Annual Meeting, officially unveiling its next-generation AI-powered cell image analysis software, CellDetect Pro. Building on the success of CellDetect, this new release integrates advanced deep learning algorithms with high-resolution microscopic imaging, marking a significant step forward in automated cytology diagnostics.

CellDetect Pro is engineered to address the growing demand for speed and accuracy in cell-based diagnostics. High-Resolution Image Recognition: Captures and processes fine cellular details at the microscopic level, ensuring no diagnostic detail is overlooked. Deep Learning-Based Classification: Automates cell type identification and abnormality detection, reducing dependence on manual interpretation. Streamlined Feature Analysis: Consolidates image recognition and data output into a single workflow, shortening the time from sample scanning to diagnostic reporting.

By presenting CellDetect Pro at TACS, Wellgen Medical reinforces its role in driving the digital transformation of clinical cytology. The software's automated approach directly reduces the workload and fatigue associated with traditional manual microscopy, while improving diagnostic consistency across cases. This launch reflects Wellgen's ongoing commitment to its core mission of "AI-Assisted Diagnosis," extending that vision into real-world clinical settings through direct engagement with the pathology community.